A virtual e-health system (VIRTUES) was as safe and effective as standard care for monitoring the function of cardiac ...
After transcatheter aortic valve implantation (TAVI), anticoagulation reduced imaging signs of clot formation on the new ...
AI-powered software from Heartflow can provide cath labs with a lot of value, according to new late-breaking data presented ...
Implementing an intersectoral, telemedicine-based intervention in nursing homes did not lead to a statistically significant ...
The traditional separation between the world of trials and the world of patient care is increasingly untenable as digital ...
Scheduling-linked alerts provide “just-in-time” trial options ahead of visits, enabling earlier identification and ...
Alexander Sheppert, DO, PhD, MBA, is an internal medicine resident physician and AI researcher and the founder of Matic. In a ...
AI-equipped prosthetics hold great promise for enabling people with disabilities to walk, speak, and work. But we cannot rely ...
NEW YORK, August 25, 2026--(BUSINESS WIRE)--Concordare Trials closed a funding round led by Surface Ventures with participation from Techstars, Innovation Works, Gaingels, and individual investors.
Phase 2 topline readout expected in Q4 2026 following patient follow-up, database lock, and unblinding POTOMAC, MD / ACCESS Newswire / / IGC Pharma, Inc. (NYSE American:IGC), a clinical-stage ...
- 17.3 month median overall survival in 55 first-line pancreatic cancer patients treated with atebimetinib in combination with chemotherapy, ...
Phase 2 topline readout expected in Q4 2026 following patient follow-up, database lock, and unblinding POTOMAC, MD / ACCESS Newswire / August 17, 2026 / IGC Pharma, Inc. (NYSE American:IGC), a clinica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results